Literature DB >> 3161894

Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein IIa.

J A van Mourik, O C Leeksma, J H Reinders, P G de Groot, J Zandbergen-Spaargaren.   

Abstract

To define the role of membrane components that function in endothelial cell physiology and to characterize them biochemically, we have attempted to prepare monoclonal antibodies specific for endothelial cells. Several clones were obtained producing antibodies which bound to endothelial cells and also to platelets. The antibody of one of these clones, CLB-HEC 75, was studied in more detail. This antibody is directed against a single protein which is synthesized constitutively by endothelial cells and is expressed on the surface of both endothelial cells and platelets. The CLB-HEC 75 antigen was isolated from Nonidet P-40-solubilized endothelial cells and platelets by immunoprecipitation and exhibited an apparent molecular weight by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of approximately 145,000 in the presence of 2-mercaptoethanol. Two-dimensional polyacrylamide gel electrophoresis and crossed immunoelectrophoresis revealed that the mobility of the CLB-HEC 75 antigen relative to platelet glycoproteins Ib, IIa, IIb, and IIIa fits previously defined criteria for platelet membrane glycoprotein IIa. The CLB-HEC 75 antigen isolated from endothelial cells co-migrated under all conditions tested with the antigen from platelets. These results indicate that endothelial cells share a plasma membrane protein indistinguishable from platelet membrane glycoprotein IIa. This protein may be a component involved in the interaction of endothelial cells with their environment including coagulation factors, platelets, and the subendothelial matrix. CLB-HEC 75 may serve as a useful tool for studying these processes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161894

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation.

Authors:  S A Bogen; H S Baldwin; S C Watkins; S M Albelda; A K Abbas
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

2.  Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family.

Authors:  H Stockinger; W Schreiber; O Majdic; W Holter; D Maurer; W Knapp
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

Review 3.  The biology of PECAM-1.

Authors:  P J Newman
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

Review 4.  PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

Authors:  Sunyoung Park; Christine M Sorenson; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

5.  Quantitative phosphoproteomics unveils temporal dynamics of thrombin signaling in human endothelial cells.

Authors:  Maartje van den Biggelaar; Juan Ramon Hernández-Fernaud; Bart L van den Eshof; Lisa J Neilson; Alexander B Meijer; Koen Mertens; Sara Zanivan
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

Review 6.  Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31).

Authors:  Panida Lertkiatmongkol; Danying Liao; Heng Mei; Yu Hu; Peter J Newman
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

7.  Human mononuclear phagocyte molecules and the use of monoclonal antibodies in their detection.

Authors:  N Hogg
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

8.  Plasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brain.

Authors:  K Hultman; M Cortes-Canteli; A Bounoutas; A T Richards; S Strickland; E H Norris
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

9.  Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO.

Authors:  I N Bird; J H Spragg; A Ager; N Matthews
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

10.  Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction.

Authors:  Manjunath Yariswamy; Tadashi Yoshida; Anthony J Valente; Hemanth Kumar Kandikattu; Siva S V P Sakamuri; Jalahalli M Siddesha; Sergiy Sukhanov; Zubaida Saifudeen; Lixin Ma; Ulrich Siebenlist; Jason D Gardner; Bysani Chandrasekar
Journal:  J Biol Chem       Date:  2016-07-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.